Neuroblastoma
|
0.160 |
Biomarker
|
disease |
BEFREE |
We show that a pair of sense/antisense lncRNA (6p22lncRNAs) encoded by CASC15 and NBAT1 located at the neuroblastoma (NB) risk-associated 6p22.3 locus are tumor suppressors and show reduced expression in high-risk NBs.
|
29533783 |
2018 |
Neuroblastoma
|
0.160 |
Biomarker
|
disease |
BEFREE |
Previous research shows that lncRNA CASC15 is implicated in the biological behaviors of several cancers such as neuroblastoma and melanoma.
|
29489064 |
2018 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASCAT |
Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.
|
28545128 |
2017 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
We confirmed that CASC15 rs6939340 A>G, rs4712653 T>C, rs9295536 C>A, LIN28B rs221634 A>T, and LMO1 rs110419 A>G were associated with significantly altered neuroblastoma susceptibility.
|
29024823 |
2017 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASCAT |
Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk.
|
28924153 |
2017 |
Neuroblastoma
|
0.160 |
AlteredExpression
|
disease |
BEFREE |
Gene expression analysis revealed downregulation of neuroblastoma-specific markers in cells with attenuated CASC15-S, with concomitant increases in cell adhesion and extracellular matrix transcripts.
|
26100672 |
2015 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
In a genome-wide association study, we identified single-nucleotide polymorphisms (SNP) associated with neuroblastoma at the CASC15, BARD1, LMO1, DUSP12, HSD17B12, HACE1, and LIN28B gene loci, but these explain only a small fraction of neuroblastoma heritability.
|
25312269 |
2014 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Several neuroblastoma (NB) susceptibility loci have been identified within LINC00340, BARD1, LMO1, DUSP12, HSD17B12, DDX4, IL31RA, HACE1 and LIN28B by genome-wide association (GWA) studies including European American individuals.
|
23222812 |
2013 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASCAT |
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
|
22941191 |
2012 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASDB |
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
|
22941191 |
2012 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASDB |
Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
|
21124317 |
2011 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASCAT |
Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
|
21124317 |
2011 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASDB |
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
|
18463370 |
2008 |
Neuroblastoma
|
0.160 |
GeneticVariation
|
disease |
GWASCAT |
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
|
18463370 |
2008 |